About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Liver Diseases group is a referent at the local, national and international level in research, and is one of the most active groups in clinical research at VHIR. The group's prominent involvement in clinical trials is a clear indication of our professionals' commitment to ensuring that patients have access to state-of-the-art therapies. Our participation and collaboration in international projects and consortiums are also a fundamental characteristic of the group. The main objective of the group is to become one of the best translational research groups in liver diseases. It is essential to be able to apply all the findings of basic research to clinical research to improve the health of patients with liver disease.
PMID: 36687413 Journal: Frontiers in Medicine Year: 2022 Reference: Front Med (Lausanne). 2023 Jan 5;9:1104382. doi: 10.3389/fmed.2022.1104382. eCollection 2022. Impact factor: Publication type: Editorail in international publication Authors: Felip, Enriqueta; Riveiro-Barciela, Mar; Suarez-Almazor, Maria E et al. DOI: 10.3389/fmed.2022.1104382
PMID: 36962761 Journal: PLOS global public health Year: 2022 Reference: PLOS Glob Public Health. 2022 Aug 17;2(8):e0000841. doi: 10.1371/journal.pgph.0000841. eCollection 2022. Impact factor: Publication type: Paper in international publication Authors: Axelsson, Maria; Buti, Maria; Diaz, Asuncion; Duffell, Erika; Fursa, Olga; Hendrickx, Greet; James, Cary; Klavs, Irena; Korenjak, Marko; Maticic, Mojca et al. DOI: 10.1371/journal.pgph.0000841
PMID: 35702721 Journal: Medicina clinica (English ed.) Year: 2022 Reference: Med Clin (Engl Ed). 2022 May 27;158(10):466-471. doi: 10.1016/j.medcle.2021.05.021. Epub 2022 Jun 9. Impact factor: Publication type: Paper in international publication Authors: Arranz-Betegon, Maria; Canas-Ruano, Esperanza; Domingo-Baldrich, Eva; Fernandez-Codina, Andreu; Garcia-Vives, Eloi; Gil-Vila, Albert; Llaneras-Artigues, Jordi; Meza, Beatriz; Michelena, Xabier; Orozco-Galvez, Olimpia et al. DOI: 10.1016/j.medcle.2021.05.021
PMID: 34537988 Journal: HEPATOLOGY Year: 2022 Reference: Hepatology. 2022 Jan;75(1):219-228. doi: 10.1002/hep.32163. Epub 2021 Dec 10. Impact factor: 17.425 Publication type: Review in international publication Authors: Hartmann, Phillipp; Gines, Pere; Castera, Laurent; Lammert, Frank; Graupera, Isabel; Serra-Burriel, Miquel; Allen, Alina M; Wong, Vincent Wai-Sun; de Knegt, Robert J; Grgurevic, Ivica et al. DOI: 10.1002/hep.32163
PMID: 34242330 Journal: PLoS One Year: 2021 Reference: PLoS One. 2021 Jul 9;16(7):e0254243. doi: 10.1371/journal.pone.0254243. eCollection 2021. Impact factor: 3.24 Publication type: Paper in international publication Authors: Llorens-Revull, Meritxell, Costafreda, Maria Isabel, Rico, Angie, Guerrero-Murillo, Mercedes, Soria, Maria Eugenia, Piriz-Ruzo, Sofia, Vargas-Accarino, Elena, Gabriel-Medina, Pablo, Rodriguez-Frias, Francisco, Riveiro-Barciela, Mar et al. DOI: 10.1371/journal.pone.0254243
PMID: 34181772 Journal: ALIMENTARY PHARMACOLOGY & THERAPEUTICS Year: 2021 Reference: Aliment Pharmacol Ther. 2021 Aug;54(4):462-469. doi: 10.1111/apt.16485. Epub 2021 Jun 28. Impact factor: 8.171 Publication type: Paper in international publication Authors: Roade, Luisa, Palom, Adriana, Sopena, Sara, Riveiro-Barciela, Mar, Carvalho-Gomes, Angela, Madejon, Antonio, Rodriguez-Tajes, Sergio, Lens, Sabela, Berenguer-Hayme, Marina, Rodriguez-Frias, Francisco et al. DOI: 10.1111/apt.16485
PMID: 34121244 Journal: TRANSPLANT INTERNATIONAL Year: 2021 Reference: Transpl Int. 2021 Oct;34(10):1908-1913. doi: 10.1111/tri.13946. Epub 2021 Jul 27. Impact factor: 3.782 Publication type: Paper in international publication Authors: Campos-Varela, Isabel, Len, Oscar, Villagrasa, Ares, Marquez-Algaba, Ester, Esperalba, Juliana, Dopazo, Cristina, Los-Arcos, Ibai, Anton, Andres, Castells, Lluis et al. DOI: 10.1111/tri.13946
PMID: 34104210 Journal: Therapeutic Advances in Gastroenterology Year: 2021 Reference: Therap Adv Gastroenterol. 2021 May 30;14:17562848211016567. doi: 10.1177/17562848211016567. eCollection 2021. Impact factor: 4.409 Publication type: Paper in international publication Authors: Campos-Varela, Isabel, Villagrasa, Ares, Simon-Talero, Macarena, Riveiro-Barciela, Mar, Ventura-Cots, Meritxell, Aguilera-Castro, Lara, Alvarez-Lopez, Patricia, Nordahl, Emilie A, Rivera-Esteban, Jesus M, Romero, Alba et al. DOI: 10.1177/17562848211016567
PMID: 31944340 Journal: HEPATOLOGY Year: 2020 Reference: Hepatology. 2020 Mar;71(3):1106-1116. doi: 10.1002/hep.31117. Impact factor: 14.679 Publication type: Review in international publication Authors: Fabrellas, Nuria, Carol, Marta, Palacio, Ester, Aban, Marites, Lanzillotti, Tommaso, Nicolao, Gea, Gines, Pere, Chiappa, Maria Teresa, Esnault, Vanessa, Graf-Dirmeier, Sabine et al. DOI: 10.1002/hep.31117
PMID: 31850577 Journal: ALIMENTARY PHARMACOLOGY & THERAPEUTICS Year: 2020 Reference: Aliment Pharmacol Ther. 2020 Jan;51(1):174-175. doi: 10.1111/apt.15558. Impact factor: 7.515 Publication type: Editorail in international publication Authors: Palom, Adriana, Riveiro-Barciela, Mar, Buti, Maria et al. DOI: 10.1111/apt.15558
PMID: 31607677 Journal: Lancet Gastroenterology & Hepatology Year: 2020 Reference: Lancet Gastroenterol Hepatol. 2020 Jan;5(1):31-41. doi: 10.1016/S2468-1253(19)30320-6. Epub 2019 Oct 10. Impact factor: 14.789 Publication type: Paper in international publication Authors: Jimenez, Cesar, Pose, Elisa, Napoleone, Laura, Amin, Ahmed, Campion, Daniela, Sola, Elsa, Uschner, Frank Erhard, de Wit, Koos, Zaccherini, Giacomo, Alessandria, Carlo et al. DOI: 10.1016/S2468-1253(19)30320-6
PMID: 31721254 Journal: ALIMENTARY PHARMACOLOGY & THERAPEUTICS Year: 2020 Reference: Aliment Pharmacol Ther. 2020 Jan;51(1):158-166. doi: 10.1111/apt.15521. Epub 2019 Nov 13. Impact factor: 7.515 Publication type: Paper in international publication Authors: Esteban, Rafael, Buti, Maria, Rodriguez, Manuel, Lens, Sabela, Riveiro-Barciela, Mar, Garcia-Samaniego, Javier, Palom, Adriana, Rodriguez-Tajes, Sergio, Navascues, Carmen A et al. DOI: 10.1111/apt.15521
The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.
Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.
On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.
Des de Vall d'Hebron estem buscant 200 persones voluntàries sanes d'entre 18 i 30 anys per a participar en un estudi sobre els patrons de consum habitual de l'alcohol en població jove, en el marc del projecte StopALD.
